Shares of Allergan were higher Wednesday after announcing plans to acquire biotech company Vitae Pharmaceuticals. Allergan has agreed to pay $639 million in cash or $21 a share. Vitae shares skyrocketed by more than 150% on the news. Allergan said the deal will strengthen its dermatology pipeline. The transaction is expected to close by the end of 2016 if it gets regulatory approval.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
